rs375947

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005535.3(IL12RB1):​c.1094T>C​(p.Met365Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.309 in 1,612,186 control chromosomes in the GnomAD database, including 78,539 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M365I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.29 ( 6814 hom., cov: 33)
Exomes 𝑓: 0.31 ( 71725 hom. )

Consequence

IL12RB1
NM_005535.3 missense

Scores

15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.948

Publications

82 publications found
Variant links:
Genes affected
IL12RB1 (HGNC:5971): (interleukin 12 receptor subunit beta 1) The protein encoded by this gene is a type I transmembrane protein that belongs to the hemopoietin receptor superfamily. This protein binds to interleukine 12 (IL12) with a low affinity, and is thought to be a part of IL12 receptor complex. This protein forms a disulfide-linked oligomer, which is required for its IL12 binding activity. The coexpression of this and IL12RB2 proteins was shown to lead to the formation of high-affinity IL12 binding sites and reconstitution of IL12 dependent signaling. Mutations in this gene impair the development of interleukin-17-producing T lymphocytes and result in increased susceptibility to mycobacterial and Salmonella infections. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
IL12RB1 Gene-Disease associations (from GenCC):
  • Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004220456).
BP6
Variant 19-18069641-A-G is Benign according to our data. Variant chr19-18069641-A-G is described in ClinVar as Benign. ClinVar VariationId is 328588.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.358 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL12RB1NM_005535.3 linkc.1094T>C p.Met365Thr missense_variant Exon 10 of 17 ENST00000593993.7 NP_005526.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL12RB1ENST00000593993.7 linkc.1094T>C p.Met365Thr missense_variant Exon 10 of 17 1 NM_005535.3 ENSP00000472165.2
IL12RB1ENST00000600835.6 linkc.1094T>C p.Met365Thr missense_variant Exon 11 of 18 1 ENSP00000470788.1

Frequencies

GnomAD3 genomes
AF:
0.295
AC:
44790
AN:
152018
Hom.:
6797
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.263
Gnomad AMI
AF:
0.250
Gnomad AMR
AF:
0.224
Gnomad ASJ
AF:
0.326
Gnomad EAS
AF:
0.372
Gnomad SAS
AF:
0.239
Gnomad FIN
AF:
0.337
Gnomad MID
AF:
0.244
Gnomad NFE
AF:
0.321
Gnomad OTH
AF:
0.291
GnomAD2 exomes
AF:
0.287
AC:
71468
AN:
248808
AF XY:
0.290
show subpopulations
Gnomad AFR exome
AF:
0.262
Gnomad AMR exome
AF:
0.168
Gnomad ASJ exome
AF:
0.337
Gnomad EAS exome
AF:
0.355
Gnomad FIN exome
AF:
0.324
Gnomad NFE exome
AF:
0.322
Gnomad OTH exome
AF:
0.284
GnomAD4 exome
AF:
0.310
AC:
453258
AN:
1460050
Hom.:
71725
Cov.:
33
AF XY:
0.309
AC XY:
224601
AN XY:
726386
show subpopulations
African (AFR)
AF:
0.261
AC:
8745
AN:
33448
American (AMR)
AF:
0.174
AC:
7788
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.333
AC:
8710
AN:
26134
East Asian (EAS)
AF:
0.388
AC:
15387
AN:
39688
South Asian (SAS)
AF:
0.231
AC:
19956
AN:
86236
European-Finnish (FIN)
AF:
0.323
AC:
17099
AN:
52912
Middle Eastern (MID)
AF:
0.303
AC:
1745
AN:
5766
European-Non Finnish (NFE)
AF:
0.320
AC:
355188
AN:
1110814
Other (OTH)
AF:
0.309
AC:
18640
AN:
60330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
15702
31404
47107
62809
78511
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11518
23036
34554
46072
57590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.295
AC:
44839
AN:
152136
Hom.:
6814
Cov.:
33
AF XY:
0.295
AC XY:
21934
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.263
AC:
10916
AN:
41516
American (AMR)
AF:
0.223
AC:
3411
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.326
AC:
1131
AN:
3468
East Asian (EAS)
AF:
0.372
AC:
1922
AN:
5170
South Asian (SAS)
AF:
0.239
AC:
1155
AN:
4826
European-Finnish (FIN)
AF:
0.337
AC:
3564
AN:
10574
Middle Eastern (MID)
AF:
0.255
AC:
75
AN:
294
European-Non Finnish (NFE)
AF:
0.321
AC:
21813
AN:
67974
Other (OTH)
AF:
0.295
AC:
624
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1701
3402
5103
6804
8505
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
460
920
1380
1840
2300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.313
Hom.:
31102
Bravo
AF:
0.284
TwinsUK
AF:
0.312
AC:
1157
ALSPAC
AF:
0.322
AC:
1242
ESP6500AA
AF:
0.258
AC:
1071
ESP6500EA
AF:
0.311
AC:
2613
ExAC
AF:
0.289
AC:
34951
Asia WGS
AF:
0.330
AC:
1149
AN:
3478
EpiCase
AF:
0.322
EpiControl
AF:
0.316

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency Benign:3
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:2
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency, variant associated with tuberculosis susceptibility -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 35% of patients studied by a panel of primary immunodeficiencies. Number of patients: 31. Only high quality variants are reported. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
0.017
DANN
Benign
0.26
DEOGEN2
Benign
0.073
T;T
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0015
N
LIST_S2
Benign
0.19
.;T
MetaRNN
Benign
0.0042
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-1.0
N;N
PhyloP100
-0.95
PrimateAI
Benign
0.26
T
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;B
Vest4
0.0060
MPC
0.097
ClinPred
0.0015
T
GERP RS
-4.5
Varity_R
0.042
gMVP
0.32
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375947; hg19: chr19-18180451; COSMIC: COSV59097336; COSMIC: COSV59097336; API